Giorgio Lamanna

Giorgio Lamanna

Auto-generated profile, based on publicly available information

Giorgio Lamanna

University of Genoa, DISSAL, Genoa - Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2013
Verified
Journal Article
Closed access
RCRenzo CORVO
Renzo CORVO
GLGiorgio Lamanna
Giorgio Lamanna
Stefano VaggeStefano Vagge
Stefano Vagge
LBLiliana Belgioia
Liliana Belgioia
DBDavide Bosetti
Davide Bosetti
ABAlmalina Bacigalupo
Almalina Bacigalupo

4 February 2015 in Tumori Journal
Verified
Journal Article
Closed access
MGMarina Guenzi
Marina Guenzi
DBDavide Bosetti
Davide Bosetti
GLGiorgio Lamanna
Giorgio Lamanna
GSGuido Siffredi
Guido Siffredi
EBElisabetta Bonzano
Elisabetta Bonzano
RCRenzo CORVO
Renzo CORVO
Background: The aim of this study was to evaluate retrospectively the planned dose distribution and acute toxicity of adjuvant hypofractionated whole breast radiotherapy (RT) delivered in the prone vs. supine position. Methods: Twenty-four patients were enrolled; 12 underwent adjuvant RT with a supine setup and 12 with a prone setup. We included patients according to breast volume (≥500 mL), disease stage (≤pT2/pN1), and clinical/biological features. Patients received a regimen of 35 Gy in 10 fractions for 2.5 weeks, and a concomitant boost of 3/4 Gy in 1 fraction/week. Target coverage was assessed by volume, V90, V95, V100, V103 and V105. Heart, LADCA and ipsilateral lung doses were evaluated according to volume, maximum dose, mean dose, V14, V10 and V5. We evaluated acute skin toxicity during RT, at the end of treatment, and after 1 month according to RTOG scales. Results: Radiobiological equivalence was warranted with satisfactory BED values: considering α/β = 4 for breast cancer, the 10-fraction schedule equaled 74 or 77 Gy depending on the boost dose (3 Gy vs. 4 Gy, respectively). Toxicity was low and similar for supine and prone treatments. Dose sparing was significant in the ipsilateral lung in the prone position (median Dmax: 28.7 Gy vs. 38.4 Gy; median Dmean: 0.8 Gy vs. 6.3 Gy; median V14:0.6% vs. 13.5%; median V5: 0 vs. 19.3%, p<0.001). Conclusions: This novel 10-fraction schedule is feasible and well tolerated; the prone position allows better saving of OARs, with a statistically significant value for the ipsilateral lung.